Shifting focus to a comprehensive COVID-19-monitoring infrastructure
The United States can explore several approaches beyond polymerase-chain-reaction testing when considering a complete COVID-19-monitoring system.
Many US states have lifted stringent shelter-at-home measures and reopened their economies. But in the country as a whole, the number of COVID-19 cases continues to rise, with a seven-day average of 47,166 new cases as of August 20, 2020.1 Several regions around the world have relied on scaled-up infrastructure for polymerase-chain-reaction (PCR) testing to serve as an essential part of early-monitoring systems for COVID-19. Those areas have principally tested across symptomatic individuals and also used other methods, such as real-time syndromic monitoring systems.
Συνέχεια ανάγνωσης εδώ
Πηγή: mckinsey
